Patents by Inventor Brendon Conlan
Brendon Conlan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20070215475Abstract: The claims describe methods for isolating functionally active Factor VIII using a membrane-based separation system containing a separation membrane to create a first and second interstitial volume between at least two restriction membranes. One or more stabilizing agents are added to the sample and/or an interstitial volume. A solvent in the first interstitial volume maintains FVIII in a desired charge state. Applying a potential between the first and second interstitial volumes separates FVIII on one side of the separation membrane from unwanted molecules on the other side of the separation membrane. These methods may also be used as a substitute for one or more steps in a conventional purification scheme for the separation of native or recombinant FVIII.Type: ApplicationFiled: December 4, 2006Publication date: September 20, 2007Inventors: Elizabeth Seabrook, Thomas Turton, Brendon Conlan
-
Patent number: 7144487Abstract: The claims describe methods for isolating functionally active Factor VIII using a membrane-based separation system containing a separation membrane to create a first and second interstitial volume between at least two restriction membranes. One or more stabilizing agents are added to the sample and/or an interstitial volume. A solvent in the first interstitial volume maintains FVIII in a desired charge state. Applying a potential between the first and second interstitial volumes separates FVIII on one side of the separation membrane from unwanted molecules on the other side of the separation membrane. These methods may also be used as a substitute for one or more steps in a conventional purification scheme for the separation of native or recombinant FVIII.Type: GrantFiled: July 15, 2002Date of Patent: December 5, 2006Assignee: Life Therapeutics, Inc.Inventors: Elizabeth Jean Seabrook, Thomas Norman Turton, Brendon Conlan
-
Patent number: 7077942Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent stType: GrantFiled: June 22, 2001Date of Patent: July 18, 2006Assignee: Gradipore LimitedInventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
-
Patent number: 7060173Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent stType: GrantFiled: June 22, 2001Date of Patent: June 13, 2006Assignee: Gradipore LimitedInventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
-
Publication number: 20050224355Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent stType: ApplicationFiled: December 7, 2001Publication date: October 13, 2005Inventors: Brendon Conlan, Tracey Edgell, May Lazar, Chenicheri Nair, Elizabeth Seabrook, Thomas Turton
-
Publication number: 20030106798Abstract: The claims describe methods for isolating functionally active Factor VIII using a membrane-based separation system containing a separation membrane to create a first and second interstitial volume between at least two restriction membranes. One or more stabilizing agents are added to the sample and/or an interstitial volume. A solvent in the first interstitial volume maintains FVIII in a desired charge state. Applying a potential between the first and second interstitial volumes separates FVIII on one side of the separation membrane from unwanted molecules on the other side of the separation membrane. These methods may also be used as a substitute for one or more steps in a conventional purification scheme for the separation of native or recombinant FVIII.Type: ApplicationFiled: July 15, 2002Publication date: June 12, 2003Applicant: Gradipore LimitedInventors: Elizabeth Jean Seabrook, Thomas Norman Turton, Brendon Conlan
-
Publication number: 20030019763Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent stType: ApplicationFiled: January 2, 2002Publication date: January 30, 2003Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
-
Patent number: 6464851Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent stType: GrantFiled: December 23, 1999Date of Patent: October 15, 2002Assignee: Gradipore LimitedInventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
-
Publication number: 20020084187Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent stType: ApplicationFiled: June 22, 2001Publication date: July 4, 2002Applicant: Gradipore LimitedInventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Haribaran Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
-
Patent number: 6402913Abstract: A method for separating components from plasma, the method comprising (I) separating the plasma into a first and second component, the first component comprising an albumin/&agr;-1-antitrypsin pool and the second component comprising plasma containing components having a molecular mass greater than albumin; (II) treating the second component to form an immunoglobulins concentrate containing immunoglobulins substantially free from components having a molecular mass less than immunoglobulins; (III) treating the immunoglobulins concentrate to remove components having a molecular mass greater than immunoglobulins; and (IV) separating albumin and &agr;-1-antitrypsin from the albumin/&agr;-1-antitrypsin pool.Type: GrantFiled: April 11, 2000Date of Patent: June 11, 2002Assignee: Gradipore LimitedInventors: Andrew Mark Gilbert, Brendon Conlan, Chenicheri Hariharan Nair
-
Publication number: 20020000386Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent stType: ApplicationFiled: August 16, 2001Publication date: January 3, 2002Applicant: Gradipore Ltd.Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
-
Patent number: RE39293Abstract: A method for separating components from plasma, the method comprising (I) separating the plasma into a first and second component, the first component comprising an albumin/?-1-antirypsin pool and the second component comprising plasma containing components having a molecular mass greater than albumin; (II) treating the second component to form an immunoglobulins concentrate containing immunoglobulins substantially free from components having a molecular mass less than immunoglobulins; (III) treating the immunoglobulins concentrate to remove components having a molecular mass greater than immunoglobulins; and (IV) separating albumin and ?-1-antitrypsin from the albumin/?-1-antitrypsin pool.Type: GrantFiled: August 1, 2003Date of Patent: September 19, 2006Assignee: Life Therapeutics LimitedInventors: Andrew Mark Gilbert, Brendon Conlan, Chenicheri Hariharam Nair